Epidemiological and quantitative study of GBV-C infection in French polytransfused children

Journal of Medical Virology

Volumn 73, Issue 4, 2004, Pages 596-600

  Castelain, S ^a   Francois, C ^a   Bonte, D ^a   Baron, A ^a   Horle, B ^a   Morel, V ^a   Pautard, B ^a   Duverlie, Gilles ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

GBV C; Polytransfused children; Quantitation; Real time PCR

Indexed keywords

TAQ POLYMERASE; VIRUS RNA;

5' UNTRANSLATED REGION; ARTICLE; BLOOD TRANSFUSION; CHILD; DISEASE COURSE; FEMALE; FOLLOW UP; FRANCE; HEPATITIS G; HEPATITIS G VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SERUM; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS STRAIN;

ADOLESCENT; BLOOD TRANSFUSION; CHILD; FEMALE; FLAVIVIRIDAE INFECTIONS; FRANCE; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

GB VIRUS C/HEPATITIS G VIRUS;

EID: 3042696411     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20131     Document Type: Article

References (28)

1. Berg T, Muller AR, Platz KP, Hohne M, Bechstein WO, Hopf U, Wiedenmann B, Neuhaus P, Schreier E. 1999. Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication. Hepatology 29:245-249.
2. Bogard M, Buffet-Janvresse C, Cantaloube JF, Biagini P, Duverlie G, Castelain S, Izopet J, Dubois M, Defer C, Lepot I, Coste J, Marcellin P, Martinot-Peignoux M, Halfon P, Gerolami V, Frangeul L, Pawlotsky JM, Roudot-Thoraval F, Dussaix E, Loiseau P, Ravera N, Lewin P, Lamoril J, Lerable J, Lebon P, et al. 1997. GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum. J Clin Microbiol 35:3298-3300.
3. Castelain S, Khorsi H, Roussel J, Francois C, Jaillon O, Capron D, Penin F, Wychowski C, Meurs E, Duverlie G. 2002. Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity. J Infect Dis 185:573-583.
4. Christensen PB, Fisker N, Mygind LH, Krarup HB, Wedderkopp N, Varming K, Georgsen J. 2003. GB virus C epidemiology in Denmark: Different routes of transmission in children and low- and high-risk adults. J Med Virol 70:156-162.
5. Chung JL, Kao JH, Kong MS, Yang CP, Hung IJ, Lin TY. 1997. Hepatitis C and G virus infections in polytransfused children. Eur J Pediatr 156:546-549.
6. Huang JJ, Lee WC, Ruaan MK, Wang MC, Chang TT, Young KC. 2001. Incidence, transmission, and clinical significance of hepatitis G virus infection in hemodialysis patients. Eur J Clin Microbiol Infect Dis 20:374-379.
7. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. 1996. Infection with hepatitis G virus among recipients of plasma products. Lancet 348:1352-1355.
8. Katayama Y, Apichartpiyakul C, Handajani R, Ishido S, Hotta H. 1997. GB virus C/hepatitis G virus (GBV-C/HGV) infection in Chiang Mai, Thailand, and identification of variants on the basis of 5′-untranslated region sequences. Arch Virol 142:2433-2445.
9. Kleinman S. 2001. Hepatitis G virus biology, epidemiology, and clinical manifestations: Implications for blood safety. Transfus Med Rev 15:201-212.
10. Komatsu H, Fujisawa T, Inui A, Sogo T, Morinishi Y, Miyagawa Y, Inui M. 1999. GBV-C/HGV infection in children with chronic hepatitis C. J Med Virol 59:154-159.
11. Kondili LA, Chionne P, Dettori S, Badolato MC, Grosso A, Vania A, Rapicetta M. 2001. GB virus C/hepatitis G virus exposure in Italian pediatric and young adult thalassemic patients. Infection 29:219-221.
12. Kumar S, Tamura K, Jakobsen IB, Nei M. 2001. MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
13. Kutyavin IV, Afonina IA, Mills A, Gorn VV, Lukhtanov EA, Belousov ES, Singer MJ, Walburger DK, Lokhov SG, Gall AA, Dempcy R, Reed MW, Meyer RB, Hedgpeth J. 2000. 3′-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res 28:655-661.
14. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK. 1996. Sequence and genomic organization of GBV-C: A novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 48:60-67.
15. Lefrere JJ, Ferec C, Roudot-Thoraval F, Loiseau P, Cantaloube JF, Biagini P, Mariotti M, LeGac G, Mercier B. 1999. GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals. J Med Virol 59:32-37.
16. Lefrere JJ, Sender A, Mercier B, Mariotti M, Pernot F, Soulie JC, Malvoisin A, Berry M, Gabai A, Lattes F, Galiay JC, Pawlak C, de Lachaux V, Chauveau V, Hreiche G, Larsen M, Ferec C, Parnet-Mathieu F, Roudot-Thoraval F, Brossard Y. 2000. High rate of GB virus type C/HGV transmission from mother to infant: Possible implications for the prevalence of infection in blood donors. Transfusion 40:602-607.
17. Linnen J, Wages J, Jr., Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW, Young L, Piatak M, Jr., Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Kim JP, et al. 1996. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 271:505-508.
18. Mercier B, Barclais A, Botte C, Cantalube J, Coste J, Defer C, Gautreau C, Giannoli C, Halfon P, Lepot I, Loiseau P, Martial J, Montcharmont P, Merel P, Ouzan D, Ravera N, Follana J, Cesaire R, Janot C, Lemaire J, De Micco P, Vezon G, Ferec C. 1999. Prevalence of GBV C/HGV RNA and GBV C/HGV antibodies in French volunteer blood donors: Results of a collaborative study. Vox Sang 76:166-169.
19. Muerhoff AS, Smith DB, Leary TP, Erker JC, Desai SM, Mushahwar IK. 1997. Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol 71:6501-6508.
20. Muerhoff AS, Tillmann HL, Manns MP, Dawson GJ, Desai SM. 2003. GB virus C genotype determination in GB virus-C/HIV co-infected individuals. J Med Virol 70:141-149.
21. Mukaide M, Mizokami M, Orito E, Ohba K, Nakano T, Ueda R, Hikiji K, Iino S, Shapiro S, Lahat N, Park YM, Kim BS, Oyunsuren T, Rezieg M, Al-Ahdal MN, Lau JY. 1997. Three different GB virus C/hepatitis G virus genotypes. Phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett 407:51-58.
22. Okamoto H, Nakao H, Inoue T, Fukuda M, Kishimoto J, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M. 1997. The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 78:737-745.
23. Pessoa MG, Terrault NA, Detmer J, Kolberg J, Collins M, Hassoba HM, Wright TL. 1998. Quantitation of hepatitis G and C viruses in the liver: Evidence that hepatitis G virus is not hepatotropic. Hepatology 27:877-880.
24. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B, Engel AM. 1996. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol 34:2660-2664.
25. Smith DB, Cuceanu N, Davidson F, Jarvis LM, Mokili JL, Hamid S, Ludlam CA, Simmonds P. 1997. Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region. J Gen Virol 78:1533-1542.
26. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
27. Toyoda H, Takahashi I, Fukuda Y, Hayakawa T, d Takamatsu J. 2000. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2- antibody in patients with hemophilia. J Med Virol 60:34-38.
28. Tucker TJ, Smuts HE. 2000. GBV-C/HGV genotypes: Proposed nomenclature for genotypes 1-5. J Med Virol 62:82-83.